Back to Search
Nortrel 1/35-28
by Barr Laboratories Llc (An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc)ContraceptionCOCP
Actively PrescribedGeneric

Estrogen

Ethinyl Estradiol

0.035Mg

Progestin

Norethindrone

1Mg

Regimen Protocol

Monophasic 28 day

Androgenicity

Moderate

Approval Date

2/28/1992

Additives
None
Inactive Ingredients
lactose monohydratepregelatinized corn starchD&C Yellow No. 10 Aluminum Lakemagnesium stearate

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Glenmark Pharmaceuticals Inc., USA

Alyacen 1/35

Northstar Rx LLC

Dasetta 1/35

Naari Pte Ltd

Norethindrone And Ethinyl Estradiol

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc

Norethindrone And Ethinyl Estradiol

Barr Laboratories Inc

Nortrel 1/35-21

Aurobindo Pharma Limited

Nylia 1/35

Have clinical questions about Nortrel 1/35-28?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy